+91-79-4107-8000
info@lincolnpharma.com
Africa Site
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial Results Of The Company
Board Meeting Outcome for OUTCOME OF BOARD MEETING
Board Meeting Intimation for Board Meeting Intimation For Inter-Alia To Consider And Approve The Un-Audited Financial Results For The Quarter And Nine-Months Ended On December 31, 2022.